Café Scientifique Topic 27: Scientific Construction of Race – Video


Café Scientifique Topic 27: Scientific Construction of Race
How much do you really know about the geographic, racial and ethnic origins of your personal ancestors? How old were you when you first learned about race? Come join us in a fascinating conversation about the evolution of race and what scientists say about race with Mike Lange, Associate Professor of Anthropology, Champlain College and John Burke, Professor, Microbiology Molecular Genetics, UVM. View the exhibit Race: Are We So Different? during social time.

By: echovermont

Link:
Café Scientifique Topic 27: Scientific Construction of Race - Video

Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 – Clinical Chemistry, Genetic …

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pcxchs/middle_east_and) has announced the addition of GlobalData's new report "Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" to their offering.

Our new report, Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture provides key market data on the Middle East and Africa In Vitro Diagnostics Market - South Africa, Israel and Saudi Arabia.

The report provides value (USD million) data for all the market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope

- Countries covered include South Africa, Israel and Saudi Arabia.. - Market size and company share data for In Vitro Diagnostics market categories - Immuno Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Microbiology Culture, Histology And Cytology and Genetic Testing. - Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018. - 2011 company shares and distribution shares data for each of the market categories and countries. - Global corporate-level profiles of key companies operating within the Middle East and Africa In Vitro Diagnostics market.

Key Topics Covered:

1 List of Tables and Figures

2 Introduction

3 In Vitro Diagnostics in Middle East and Africa

Read the original here:
Research and Markets: Middle East and Africa In Vitro Diagnostics Market Outlook to 2018 - Clinical Chemistry, Genetic ...

Recent advances in Microbiology – Rapid Mycoplasma Test

SMis Pharmaceutical Microbiology conference taking place on the 30th & 31st January London will provide attendees with an expert and highly accredited speaker line who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry.

London (PRWEB UK) 9 January 2013

SMi is pleased to confirm John Duguid, Principle Analytical Scientist, Genzyme as a speaker at the upcoming event. Mr. Duguid is currently responsible for developing, validating, and transferring molecular biology assays for rapid microbiology and cell differentiation application s, managing complex projects to implement process changes, and using statistical process control tools to implement process analytical technology for cell therapy products

He will address the selection, validation and automation of rapid mycoplasma test, looking at how to do a selection using a risk based approach, validation according to PhEur 2.6.7 and automation for routine testing. Attending will enable delegates to hear

Over 13 speakers from top pharma companies that include Sanofi-Aventis, Genzyme, GlaxoSmithKline, Pfizer, Merck and MedImmune

For more information visit http://www.smi-online.co.uk/goto/pharma-microbiology59.asp alternatively contact Cem Tuna on +44 0 207 827 6184 or email on ctuna(at)smi-online(dot)co(dot)uk

Sonal Patel SMi Group Ltd 0207 827 6106 Email Information

Here is the original post:
Recent advances in Microbiology – Rapid Mycoplasma Test

Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/tg7hqs/microbiology) has announced the addition of GlobalData's new report "Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018" to their offering.

The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within seven market categories - Bacterial Identification & Susceptibility Testing, Blood Culture, Mycobacteria Culture, Microbiology Analyzers, Immunological Culture Identification, Parasitology Culture and Mycology Culture.

The report also provides company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.

Scope

- Market size data for Microbiology Culture market categories

- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the seven market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.

- 2011 company shares and distribution shares data for the overall Microbiology Culture market in each of the aforementioned countries.

- Global corporate-level profiles of key companies operating within the Microbiology Culture market in BRICS.

Reasons to Buy

See original here:
Research and Markets: Microbiology Culture Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018

Longevity Global Inc Brings a New Range of Welder Machines and Welding Equipment

Offering attractive discounts on welding equipment and welder machines, Longevity Global Inc is fast becoming a one-stop online shop for welding services providers. Thus, catering the requirement for durable and high-end welder equipment for DIY, the company provides user-friendly buying experience i.e. buyers can browse through a range of welding machines and equipment before deciding the right one.

Hayward, Ca (PRWEB) January 11, 2013

Longevity Global Inc is innovative and for decades has been bringing up fine range of welding machines and equipment that are being used in by the companies for welding purposes in large and small scales. The company provides durable and higher performance welder machines to users designed and developed through innovation and that is why it has been able to meet customer satisfaction.

Being a leading production company it also brings welders for sale wherein it sells them at attractively lower prices and provides attractive discounts. Longevity Global Inc is known for offering fine range of welding machines and others for customers in in the countries such as Brazil, Australia, UK, Mexico, Canada wherein it has developed a network of distributors.

It also has a welding forum wherein users can talk and discuss the machines and tools that are of their use. Talking about the feature, a company professional said, With our welding forum you access to view some welding discussions, access to our other features such as contests and giveaways for welding equipment, and lots of member only privileges. He further says that there are limitations for guests; however, there are no restrictions for members.

About the company:

LONGEVITY Global Inc is recognized worldwide for providing reliable welding, and power generating equipment. Since its inception 2001, LONGEVITY has earned the slogan, "The Power to Last" through innovation, customer satisfaction, and industry leading production. Welding, cutting, and power generating equipment from the company have exceptional quality and durability achieved through R &D department. It has no excuse DOA policy, and samples products to the top welders in the United States to receive crucial feedback, which drives innovation.

For more information please visit http://www.longevity-inc.com

Simon Katz Longevity, Inc. 1.877.566.4462 Email Information

Read more from the original source:
Longevity Global Inc Brings a New Range of Welder Machines and Welding Equipment

Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1) – Video


Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1)
This video is meant to give you a taste of what biology labs can be like in a co-op setting. I set up a camera at one end of the room and let it run while we did Experiment 10.1 during Co-op Week 9. It really is necessary for the students to talk as they work in pairs, so it can get a bit noisy. Also, this particular week our classroom was open to the musical rehearsal in the room next to us (the folding wall was broken) so it was a bit more noisy than normal, but the video will still give you a good idea of how labs in a group setting can look.

By: Conniethedaisyhead

Continue reading here:
Biology Labs as Coop Class (Apologia Biology Experiment Module 10.1) - Video

The New v.3.0 Atheism – Video


The New v.3.0 Atheism
Dr. Norman Geisler A 2013 perspective. Microbiologist Michael Behe: "The impotence of Darwinian theory in accounting for the molecular basis of life is evident not only from the analyses in this book, but also from the complete absence in the professional scientific literature of any detailed models by which complex biochemical systems could have been produced, as shown in Chapter 8. In the face of the enormous complexity that modern biochemistry has uncovered in the cell, the scientific community is paralyzed. No one at Harvard University, no one at the National Institutes of Health, no member of the National Acacemy of Sciences, no Nobel prize winner mdash;no one at all can give a detailed account of how the cilium, or vision or blood clotting or any complex biochemical process might have developed in a Darwinian fashion. But we are here. Plants and animals are here. The complex systems are here. All these things got here somehow: if not in a Darwinian fashion, then how?"

By: pbar1000

Read this article:
The New v.3.0 Atheism - Video

Building a Diverse Future for the Biological Sciences – Video


Building a Diverse Future for the Biological Sciences
(Visit: http://www.uctv.tv Panel analyzes the double bind in the biological sciences, assessing the pipeline and the potential for building a more diverse faculty. Moderated by Ram Seshadri, Associate Director of the Materials Research Lab Professor of Materials, Chemistry Biochemistry, UC Santa Barbara. Panelists: Albert Bennett, Dean of School of Biological Sciences Professor, Ecology and Evolutionary Biology, UC Irvine; Diane O #39;Dowd, Department Chair Professor of Developmental and Cell Biology, UC Irvine; Luis Mota-Bravo, Director, Outreach, Research Training and Minority Science Programs, UC Irvine Series: "Building Capacity for Institutional Transformation in the Twenty-First Century: Women of Color in STEM and SBS Fields - UC ADVANCE " [1/2013] [Education] [Show ID: 24625]

By: UCtelevision

View post:
Building a Diverse Future for the Biological Sciences - Video

Artificial “Poop” Cures Gut Superbug C. Difficile

Featured Article Academic Journal Main Category: GastroIntestinal / Gastroenterology Also Included In: Infectious Diseases / Bacteria / Viruses;MRSA / Drug Resistance;Biology / Biochemistry Article Date: 11 Jan 2013 - 9:00 PST

Current ratings for: Artificial "Poop" Cures Gut Superbug C. Difficile

1 (1 votes)

5 (1 votes)

The synthetic stool, called RePOOPulate, is the creation of Emma Allen-Vercoe, a microbiologist at the University of Guelph in Canada.

Allen-Vercoe is also the senior author of a paper describing a study of the artificial "super-probiotic" poop that was published in the first issue of a new online, peer-reviewed science journal Microbiome on Wednesday.

As a consequence, the bacterium overpopulates the gut, producing nasty toxins, when healthy, less resistant, gut bacteria are killed off by antibiotics.

Outbreaks resulting from recurring infections of C. difficile tend to occur where lots of people who are either sick or vulnerable to illness are under one roof, such as in hospitals and residential care homes.

For example, one study, reported at a conference in the US in October 2012, showed how treating patients with donated human stool mixed with water through a nasogastric tube or colonoscopy resulted in a complete and fast recovery with no negative side effects in 43 out of 49 of them.

But Allen-Vercoe says in a press statement, while stool transplants using fecal matter from healthy people is an effective therapy for recurring C. difficile infections, they carry the risk of introducing other unknown pathogens, which potentially "puts people at risk for future disease".

See more here:
Artificial "Poop" Cures Gut Superbug C. Difficile

IP Resources Arranges Licensing Deal for New Stem Cell Skin Care Product on Forbes List of Top 10 Fashion and Beauty …

LOS ANGELES, CA--(Marketwire - Jan 10, 2013) - Hanover Portfolio Acquisitions ( OTCQB : HVPA ) and its wholly owned subsidiary IP Resources International, an intellectual property licensing and commercialization company, announced today that it has concluded an international commercialization and licensing agreement with Personal Cell Sciences Corp., the developer of U Autologous, a skin care suite that uses a person's own stem cells to create "the world's first skin care line designed and created especially for you."

IP Resources has participated in the development of an exclusive license between Personal Cell Sciences and BALS Holdings Limited for the commercialization and distribution of Personal Cell Sciences' U Autologous skin care line in Hong Kong and Macau. As a result of the transaction, IP Resources is to receive royalty revenues from the distributor's future sales of U Autologous products in Hong Kong and Macau.

U Autologous is a cutting-edge innovative personalized anti-aging skin care line developed by Personal Cell Sciences Corp. The proprietary ingredient Autokine-CM is created through a manufacturing and processing collaboration with American CryoStem Corporation. To create the U-Autologous product, Adipose Tissue (fat) is collected from the customer using American CryoStem's proprietary, CELLECT adipose tissue collection system and processed at American CryoStem's laboratory to create the individual's unique Autokine-CM. Personal Cell Sciences and U Autologous Skin Care were listed on the Forbes Top 10 Fashion and Beauty Startups for 2012 and as the "Biggest Beauty Breakthrough of 2012" by Glamour.com

Hong Kong and Macau are special administrative regions of the People's Republic of China. According to MarketLine, the Asia-Pacific skincare market had total revenues of $41.9 billion in 2011, representing a compound annual growth rate (CAGR) of 4.6% between 2007 and 2011. Market growth is expected to accelerate and to reach $57.8 billion by 2016.

"With Hong Kong and Macau being major luxury shopping destinations for mainland China, one of the largest and fastest growing skin care markets in the world, we believe Personal Cell Sciences' personalized skin care line will gain traction in this thriving market," stated Alan Collier, CEO and Chairman of Hanover Portfolio Acquisitions and IP Resources International. "This licensing transaction is an important milestone and example of IP Resources' ability to execute on its core business of commercializing and monetizing innovative technologies through joint ventures and international licensing agreements."

American CryoStemAmerican CryoStem Corporation is a leading biotech company focused on marketing its clinical processing services and patented products for adipose (fat) tissue and adipose derived adult stem cells. Our clinical tissue processing, patented cell culture media products and tissue storage platform supports cosmetic and regenerative medicine applications being developed globally. The Company provides high quality, clinically processed viable cells, while at the same time developing cutting edge applications, therapies, patented laboratory products and services for consumer and commercial applications.

About Hanover Portfolio Acquisitions & IP Resources InternationalHanover Portfolio Acquisitions, through its wholly owned subsidiary, IP Resources International, is an intellectual property management firm that specializes in the commercialization of compelling technologies through joint ventures and international licensing. The Company specializes in the commercialization of technologies within the healthcare, energy, consumer electronics, and internet industries.

Safe Harbor StatementThis press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements, trends, analysis, and other information contained in this press release including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend," and other similar expressions of opinion, constitute forward-looking statements. Any such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from any future results described within the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

See the original post:
IP Resources Arranges Licensing Deal for New Stem Cell Skin Care Product on Forbes List of Top 10 Fashion and Beauty ...

Top medicine articles for December 2012-January 2013

Here are my suggestions for some of the top articles in medicine for December 2012-January 2013:

Among former Olympic athletes, engagement in disciplines with high intensity exercise did not bring a survival benefit http://buff.ly/UmY9Ur

Non-benzodiazepine hypnotics (Z drugs - eszopiclone, zaleplon, zolpidem) are effective for treatment of adult insomnia http://buff.ly/UZC1g9

Bringing surgical history to life | BMJ http://buff.ly/UZCeQC -- Things change fast in surgery. Within a single generation, ways of operating that had been stable for decades have been overturned. New drugs have revolutionized what were once “surgical” conditions, and minimally invasive procedures have driven many “open” operations to the verge of extinction.

Dabigatran Shouldn't Be Used in Patients with Mechanical Heart Valves http://buff.ly/UmXToo

Confront medical errors - The University of Michigan Health System pioneered the three principle approach of “disclose, apologize, offer” more than a decade ago. http://buff.ly/UZDeV0

One Question That Changed the Cleveland Clinic Organization:
"How do you teach empathy?" CEO explains: http://buff.ly/V1ntgi

Too Young to Have a Heart Attack, at 48 - NYTimes http://buff.ly/UvpYKd

The Perils of Yoga for Men - torn muscles, damaged ligaments, dislocated joints, broken bones http://buff.ly/UwxhBp

Doctor Sued for Following a 'Do Not Resuscitate Order (found not liable by the jury) http://buff.ly/UZzYZH

Consequence of prescription-pain-pill epidemic: babies born dependent on drugs such as oxycodone http://buff.ly/V80BvE

50% of new experimental treatments prove to be better than established treatments, but few are much better http://buff.ly/PLDqJt

Exercise Minutes Per Week as a Vital Sign? http://buff.ly/11aAHxp

Asleep at the Wheel: 'Drowsy Driving' affects 4% of survey responders http://buff.ly/11aAQRg

Some U.S. Few Medical Schools Now Offering 3-Year Degrees http://buff.ly/WrCSoC

The articles were selected from my Twitter and Google Reader streams. Please feel free to send suggestions for articles to clinicalcases AT gmail.com and you will receive acknowledgement in the next edition of this publication.

Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.

Source:
http://feedproxy.google.com/~r/CasesBlog/~3/Wj4AuVBbR78/top-medicine-articles-for-december-2012.html

Things to know about the real fountain of youth

Fountain of youth is referred to a spring. If a person drinks the water of it, he or she can easily restore the youth again in themselves. In his writing Herodotus has also mentioned about this concept. This has become a kind of legend and many a famous author like Homer or Shakespeare have also discussed about in the literature. Now the biggest question is that whether there is really any kind of such fountain on this earth or not.

How the search goes on:

The search of such a fountain goes generation after generation because men have always wanted more youth. With the progress of science men have made many an incredible thing successful. The use of stem cells and many other related inventions have made huge change in human life. Men and women are getting longer and fitter life. More researches on cells are going on and scientists are working very hard to invent various things by the help of which we can keep our youth for longer time.

What the concept is:

Though the whole thing comes from a myth but the main aspect of this thought is to get back the life again. Man has always searched for immortality. According to scientists, now they have found out a way to continue your youth for longer time. Actually our body can have the charm of youth because of cell division. Normally a cell can divide for fifty times and then gradually it stops and the characteristics of old age begin to come in the body. Now the scientists have succeeded to produce such a cell which can divide it over 90 times and still it will not get slow down. Scientists have used an enzyme with the chromosomes the name of which is Telomerase. Telomere shortening is the actual reason of gradually getting old. Now this enzyme will stop the normal shortening process of telomere and thus it can help you to keep your youth in yourself for longer time.

Its drawback:

This enzyme is undoubtedly one of the most incredible inventions at the moment but it may have some drawbacks. According to some of the scientists this shortening process of telomere is a natural process. Now this natural process can eventually ward off cancer. Now by adding this enzyme this natural process of body defense will be destroyed. Some of the scientists are worried of the consequences of that. More experiments are going on and after the successful completion of them the scientists will be able to state the result of this new invention.

Searching for longer life:

Most of the people on this earth like to have a longer life especially a longer youth in which he will have ample energy to enjoy all the entertaining aspects of life. The concept of fountain of youth has been traditionally carried forward generation after generation because of this continuous wish of longer life of human being.

The myth of finding a fountain where the water can be found which can bring back youth may not be found physically. However, progress of science can assure a longer youth for human. In recent future man is going to live a longer enjoyable life.

About The Author: Claudia is a writer/ blogger. She loves writing, travelling and reading books. She contributes to Caribbean Cruise Line Scam 

Source:
http://www.biotechblog.org/entry/real-fountain-youth/